Rinvoq 30 mg
The same active substance, strength and form as listed by each country’s medicines regulator. For showing a pharmacist abroad.
- Active substance
- Upadacitinib
- Strength
- 30 mg
- Form
- Tablet, Extended Release
- ATC code
- Not stated by the register
- Registered in
- United States · AbbVie Inc.
- Prescription
- Prescription only
- NDC
- 0074-2310
Source: NDC Directory · 2026-09-13
Not a prescription. Not a statement that these products are interchangeable. Products are matched on active substance, strength and kind of form only. Other ingredients, release, approved uses and the dose on the box can differ. A pharmacist or doctor decides whether one can replace another.
Listed in other countries
Spain 2 matching products
| Name on the box | Strength and form | Prescription | Holder | Official record |
|---|---|---|---|---|
| RINVOQ | 30 mg · comprimido de liberación prolongada | Prescription only | Abbvie Deutschland Gmbh & Co. Kg (+1) | 1191404006 |
Source: CIMA — Centro de Información online de Medicamentos (Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)) · 2026-09-30 · Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA.
Canada 1 matching products
| Name on the box | Strength and form | Prescription | Holder | Official record |
|---|---|---|---|---|
| RINVOQ | 30 mg · tablet (extended-release) | Prescription only | Abbvie Corporation | 02520893 |
Source: Drug Product Database (Health Canada) · 2026-09-30 · Contains information licensed under the Open Government Licence – Canada.
Same active substance, but no match for this strength and form
- European Union: 1 products · Every strength and form